Table 3.
Treatments1 | P-value2 | |||||||
---|---|---|---|---|---|---|---|---|
Item | CON | NAR | LAS | VRM | SEM | Treatment | Day | T × D |
Rumen pH | 6.85b | 6.79b | 6.84b | 6.98a | 0.04 | 0.03 | <0.01 | 0.19 |
Ammonia, mg/dL | 4.18 | 4.28 | 4.25 | 4.87 | 0.77 | 0.11 | <0.01 | 0.17 |
Total SCFA, mM | 87.13b | 101.51a | 87.17b | 90.35b | 6.92 | 0.02 | <0.01 | <0.01 |
SCFA, mM/100mM3 | ||||||||
Acetate | 74.91a | 73.14b | 74.61a | 74.98a | 0.38 | <0.01 | <0.01 | <0.01 |
Propionate | 14.53b | 16.28a | 14.84b | 14.49b | 0.22 | <0.01 | <0.01 | <0.01 |
Butyrate | 7.80 | 7.75 | 7.62 | 7.71 | 0.14 | 0.78 | <0.01 | 0.54 |
Isobutyrate | 0.87 | 0.87 | 0.88 | 0.89 | 0.02 | 0.84 | <0.01 | 0.47 |
Valerate | 0.87 | 0.85 | 0.85 | 0.88 | 0.08 | 0.95 | <0.01 | 0.87 |
Isovalerate | 1.05 | 1.10 | 1.11 | 1.09 | 0.02 | 0.27 | <0.01 | 0.11 |
Acetate:propionate | 5.18b | 4.52a | 5.04b | 5.20b | 0.06 | <0.01 | <0.01 | <0.01 |
1CON, no feed additives; NAR, inclusion of 13 mg/kg of dry matter (DM) of narasin (Zimprova; Elanco Animal Health, São Paulo, SP, Brazil); LAS, inclusion of 20 mg/kg of DM of lasalocid (Taurotec; Zoetis, Sao Paulo, SP, Brazil; n = 8); VRM, inclusion of 20 mg/kg of DM of virginiamycin (V-Max; Phibro Animal Health Corporation, Guarulhos, SP, Brazil; n = 8).
2 P-value for treatment, day, and treatment × day interaction (T × D).
3On day 0 (immediately prior to the beginning of the experimental period and first treatment offer), 28, 56, 84, 112, and 140 of the experimental periods at 0, 6, and 12 h after feeding concentrate + treatments, ruminal fluid samples were collected (approximately 100 mL).